Global Impotence Agents Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Impotence Agents Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Impotence agents are the type of agents that used to treat erectile dysfunction in males and enable to increase sexual intercourse. These agents generally increase vasodilation and blood flow to the male genital organ and cause an erection. It is becoming of great importance to the healthcare sector and is expected to expand in the coming times.
Impotence Agents report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Impotence Agents market is projected to reach US$ 5102.8 million in 2029, increasing from US$ 3241 million in 2022, with the CAGR of 6.7% during the period of 2024 to 2029. Demand from Erectile Dysfunction and Premature Ejaculation are the major drivers for the industry.
Rising burden of lifestyle diseases and growing prevalence of sedentary lifestyles have led to the expansion of the erectile dysfunction drugs market size. Leading to an increasing incidence of erectile dysfunction (ED) worldwide. According to the World Health Organization (WHO), erectile dysfunction affects approximately 15% of the male population each year and is expected to reach 320 million by 2025. Hence, increasing prevalence of diseases and rising demand for ED drugs is one of the key factors driving the market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Impotence Agents market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Pfizer Inc
Bayer AG
Novartis AG
Hikma Pharmaceuticals plc
Aurobindo Pharma
VIVUS LLC.
Petros Pharmaceuticals, Inc.
Bristol-Myers Squibb Company
GSK PLC
Sanofi
Teva Pharmaceuticals Industries Ltd
Lilly
Adamed
Sun Pharmaceutical Industries, Ltd.
Auxilium Pharmaceuticals, Inc.
Segment by Type
Oral Preparation
Injection
Other
Erectile Dysfunction
Premature Ejaculation
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Impotence Agents market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Impotence Agents, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Impotence Agents industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Impotence Agents in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Impotence Agents introduction, etc. Impotence Agents Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Impotence Agents market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Impotence Agents report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Impotence Agents market is projected to reach US$ 5102.8 million in 2029, increasing from US$ 3241 million in 2022, with the CAGR of 6.7% during the period of 2024 to 2029. Demand from Erectile Dysfunction and Premature Ejaculation are the major drivers for the industry.
Rising burden of lifestyle diseases and growing prevalence of sedentary lifestyles have led to the expansion of the erectile dysfunction drugs market size. Leading to an increasing incidence of erectile dysfunction (ED) worldwide. According to the World Health Organization (WHO), erectile dysfunction affects approximately 15% of the male population each year and is expected to reach 320 million by 2025. Hence, increasing prevalence of diseases and rising demand for ED drugs is one of the key factors driving the market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Impotence Agents market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Pfizer Inc
Bayer AG
Novartis AG
Hikma Pharmaceuticals plc
Aurobindo Pharma
VIVUS LLC.
Petros Pharmaceuticals, Inc.
Bristol-Myers Squibb Company
GSK PLC
Sanofi
Teva Pharmaceuticals Industries Ltd
Lilly
Adamed
Sun Pharmaceutical Industries, Ltd.
Auxilium Pharmaceuticals, Inc.
Segment by Type
Oral Preparation
Injection
Other
Segment by Application
Erectile Dysfunction
Premature Ejaculation
Other
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Impotence Agents market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Impotence Agents, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Impotence Agents industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Impotence Agents in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Impotence Agents introduction, etc. Impotence Agents Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Impotence Agents market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices